Search alternatives:
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
potent therapeutic » potential therapeutic (Expand Search), potential therapeutics (Expand Search), novel therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
Showing 61 - 80 results of 4,352 for search '(( ((decrease therapeutic) OR (potent therapeutic)) research ) OR ( decrease host resistance ))', query time: 0.65s Refine Results
  1. 61
    Figure S7 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S7 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  2. 62
    Figure S2 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S2 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  3. 63
    Figure S9 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S9 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  4. 64
    Figure S8 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S8 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  5. 65
    Figure S4 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S4 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  6. 66
    Figure S6 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

    Figure S6 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors by Licui Jiang (20366341)

    Published 2024
    Save to List
    Saved in:
  7. 67
    Supplementary Figure 1 from Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer

    Supplementary Figure 1 from Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer by Rebecca A. Previs (13990744)

    Published 2023
    Save to List
    Saved in:
  8. 68
    Table S3 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

    Table S3 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF by Wenlin Shao (2472)

    Published 2023
    Save to List
    Saved in:
  9. 69
    Table S5 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

    Table S5 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF by Wenlin Shao (2472)

    Published 2023
    Save to List
    Saved in:
  10. 70
    Table S2 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

    Table S2 from Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF by Wenlin Shao (2472)

    Published 2023
    Save to List
    Saved in:
  11. 71
    Figure S7 from Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein

    Figure S7 from Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein by Michael D. Oberst (15003572)

    Published 2023
    Save to List
    Saved in:
  12. 72
    Figure S4 from Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein

    Figure S4 from Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein by Michael D. Oberst (15003572)

    Published 2023
    Save to List
    Saved in:
  13. 73
    Supplementary Table 1 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity

    Supplementary Table 1 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity by Manman Zhu (19274894)

    Published 2024
    Save to List
    Saved in:
  14. 74
    Supplementary Table 3 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity

    Supplementary Table 3 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity by Manman Zhu (19274894)

    Published 2024
    Save to List
    Saved in:
  15. 75
    Supplementary Table 4 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity

    Supplementary Table 4 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity by Manman Zhu (19274894)

    Published 2024
    Save to List
    Saved in:
  16. 76
    Supplementary Table 2 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity

    Supplementary Table 2 from Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity by Manman Zhu (19274894)

    Published 2024
    Save to List
    Saved in:
  17. 77
    Supplemental Movie 1 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin

    Supplemental Movie 1 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin by Samriddhi Shukla (321547)

    Published 2023
    Save to List
    Saved in:
  18. 78
    Supplemental Movie 3 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin

    Supplemental Movie 3 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin by Samriddhi Shukla (321547)

    Published 2023
    Save to List
    Saved in:
  19. 79
    Supplemental Movie 2 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin

    Supplemental Movie 2 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin by Samriddhi Shukla (321547)

    Published 2023
    Save to List
    Saved in:
  20. 80
    Supplemental Movie 4 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin

    Supplemental Movie 4 from The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin by Samriddhi Shukla (321547)

    Published 2023
    Save to List
    Saved in:

Search Tools: